Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730450) titled 'A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age' on July 23.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).

Primary Sponsor: BioNTech SE

Condition: COVID-19 Vaccines

Intervention: Biological: BNT162b2 Vaccine

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 23, 2026

Target Sample Size: 200

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07730450

Disclaim...